You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenosine Deaminase

Showing 1 - 25 of 513
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Adenosine deaminase serum level
  • IgE antibodies serum level
  • (no location specified)
Aug 7, 2023

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

Not yet recruiting
  • Pleural Effusion, Malignant
  • pleural markers
  • (no location specified)
Jan 20, 2023

Adenosine Deaminase Enzyme Deficiency in Lymphopenia and/or

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • ADENOSINE DEAMINASE TEST
  • Konya, Meram, Turkey
    Konya Necmettin Erbakan University
Mar 18, 2022

Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

Not yet recruiting
  • Adenosine Deaminase Severe Combined Immune Deficiency
  • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
  • (no location specified)
Jun 20, 2022

Adenosine Deaminase Enzyme Deficiency Disease in Adult Pulmonary

Enrolling by invitation
  • Pulmonary Alveolar Proteinosis
  • adenosine deaminase test
  • Istanbul, Maltepe, Turkey
    Istanbul Yedikule Chest Diseases and Thoracic Surgery Training a
Mar 18, 2022

Investigation of ADA Enzyme Deficiency

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • adenosine deaminase test
  • Ankara, Mamak, Turkey
    Ankara Üniversitesi Tıp Fakültesi
Mar 18, 2022

Enzyme Deficiency in Pulmonology Clinics (ADA)

Active, not recruiting
  • Bronchiectasis
  • +2 more
  • adenosine deaminase enzyme deficiency test
  • Ankara, Mamak, Turkey
    Ankara University Medical Faculty
Mar 18, 2022

Patients Previously Treated With Autologous ex Vivo Gene Therapy

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • Severe Combined Immunodeficiency (SCID)
  • autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)
  • Los Angeles, California
  • +1 more
Mar 31, 2022

Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)

Completed
Has Results
  • Adenosine Deaminase Deficiency
  • Severe Combined Immunodeficiencies (SCID)
  • Infusion of autologous EFS-ADA LV CD34+ cells
  • +3 more
  • London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust
Aug 20, 2021

Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)

Enrolling by invitation
  • Immunologic Deficiency Syndromes
  • Strimvelis
  • Milano, Lombardia, Italy
    Orchard Investigational Site
Jun 23, 2021

Severe Combined Immunodeficiency Due to ADA Deficiency Trial in London (Infusion of autologous cryopreserved EFS-ADA LV CD34+

Active, not recruiting
  • Severe Combined Immunodeficiency Due to ADA Deficiency
  • Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)
  • +2 more
  • London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust
Dec 17, 2021

Severe Combined Immunodeficiency Trial in Los Angeles (ADA gene transfer)

Completed
Has Results
  • Severe Combined Immunodeficiency
  • ADA gene transfer
  • Los Angeles, California
    University of California, Los Angeles
Apr 21, 2021

Periodontitis Trial in Van (No intervention was applied to the groups the samples will be collected in terms of the diagnosis

Recruiting
  • Periodontitis
  • No intervention was applied to the groups the samples will be collected in terms of the diagnosis (hopeless, periodontitis, gingivitis, healthy)
  • Van, Turkey
    Van yuzuncu yil university
Nov 21, 2020

ADA-SCID, Adenosine Deaminase Deficiency, Severe Combined Immunodeficiency Trial in United States (EZN-2279, Adagen)

Completed
Has Results
  • ADA-SCID
  • +2 more
  • EZN-2279
  • Adagen
  • Los Angeles, California
  • +5 more
Apr 6, 2020

Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID) Trial in Shenzhen (TYF-ADA gene-modified autologous stem cells)

Unknown status
  • Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)
  • TYF-ADA gene-modified autologous stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Sep 18, 2019

Severe Combined Immunodeficiency Syndrome Trial run by the NHGRI (CD34+ cells transduced with ADA retrovir)

Completed
  • Severe Combined Immunodeficiency Syndrome
  • CD34+ cells transduced with ADA retrovir
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019

Purinergic Signaling and the Postmenopausal Heart

Recruiting
  • Diastolic Heart Failure
  • Heart Failure With Preserved Ejection Fraction
  • Gender
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 28, 2023

Pleural Effusion Trial in Jakarta Pusat (procedure, diagnostic test, drug)

Not yet recruiting
  • Pleural Effusion
  • Medical thoracoscopy
  • +2 more
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Respirology and Critical Illness Division, Department of Interna
Sep 21, 2022

Cancer in Inherited Bone Marrow Failure Syndromes

Recruiting
  • Diamond Blackfan Anemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 24, 2023

    Primary Membranous Nephropathy Trial in Beijing (B007)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • Beijing, China
      Peking university first hospital
    Dec 20, 2022

    Transthoracic Ultrasound in Differentiating Tuberculous From

    Recruiting
    • Pleural Effusion
    • +2 more
      • Kuching, Sarawak, Malaysia
        Sarawak General Hospital
      Jun 28, 2023

      Retroviral Insertion Site Analysis in Strimvelis Gene Therapy

      Enrolling by invitation
      • Severe Combined Immunodeficiency Due to ADA Deficiency
      • Retroviral Insertion Site Analysis
      • Milan, Italy
        Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
      Feb 17, 2022

      Immune-mediated Diseases

      Recruiting
      • Primary Immunodeficiency
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 10, 2023

        Tuberculosis Trial (zinc 50 mg + Epigallocatechin gallate)

        Not yet recruiting
        • Tuberculosis
        • zinc 50 mg + Epigallocatechin gallate
        • (no location specified)
        Nov 1, 2021

        NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

        Not yet recruiting
        • NonHodgkin's Lymphoma Refractory
        • El Segundo, California
          CSSIFM
        Nov 9, 2022